cannabis indica

Intoxicação por Cannabis Sintética

termo de indexação original: Poisoning by Synthetic Cannabis

O acervo do Cannabis Indica reúne 137 estudos científicos que tocam a condição Intoxicação por Cannabis Sintética, publicados entre 1977 e 2023. Pela leitura automatizada, 24 (18%) foram classificados como favoráveis, 14 (10%) como inconclusivos e 99 (72%) como desfavoráveis — uma leitura de máquina, feita para navegar, não para concluir. O desenho mais frequente é metanálise (95 estudos), seguido de estudo em animais (15). Os compostos mais presentes são Canabinoide Sintético (não especificado), Canabinoides Sintéticos JWH-x e Canabinoides Sintéticos 5F-x. Aparece com frequência ao lado de Efeitos Adversos da Cannabis, Psicose e Doenças Cardiovasculares (DCV).

Estudos indexados
137
Período coberto
1977–2023
Favoráveis
24 · 18%
Inconclusivos
14 · 10%
Desfavoráveis
99 · 72%
Termo original
Poisoning by Synthetic Cannabis

O acervo em números

Tipo de estudo

Metanálise95
Estudo em Animais15
Ensaio Clínico12
Ensaio Clínico Duplo-Cego9
Estudo Laboratorial5
Metanálise Clínica1

Direção do resultado

Favorável24
Inconclusivo14
Desfavorável99

Por década

1970s1
1990s1
2000s2
2010s86
2020s47

137 estudos

Filtrar e buscar no acervo →
  1. 2023

    'Flying high?'-Jump from a height in a 'Spice' high?: A case report on the synthetic cannabinoid 5F-MDMB-P7AICA

  2. 2023

    A Fatal Case Report Resulting from the Abuse of the Designer Benzodiazepines Clonazolam and Flualprazolam in Conjunction with Dried Opium Poppy Pods

  3. 2023

    CB1 receptor expression and signaling are required for dexamethasone-induced aversive memory consolidation

  4. 2023

    Instant Detection of Synthetic Cannabinoids on Physical Matrices, Implemented on a Low-Cost, Ultraportable Device

  5. 2023

    Marijuana as a Cause of Diffuse Coronary Vasospasm Leading to Cardiac Arrest

  6. 2023

    Methyl (S)-2-(1-7 (5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (5F-MDMB-PICA) intoxication in a child with identification of two new metabolites (ultra-high-performance liquid chromatography-tandem mass spectrometry)

    DesfavorávelMetanáliseCanabinoides Sintéticos 5F-x
  7. 2023

    Monitoring Perfusion Index in Patients Presenting to the Emergency Department Due to Drug Use

  8. 2023

    Persistent Coagulopathy After Synthetic Cannabinoid Use

    DesfavorávelMetanáliseCanabinoide Sintético (não especificado)
  9. 2023

    Quantitative Analysis of Three Synthetic Cannabinoids MDMB-4en-PINACA, ADB-BUTINACA, and ADB-4en-PINACA by Thermal-Assisted Carbon Fiber Ionization Mass Spectrometry

  10. 2023

    Synthetic Cannabinoids and ST-Elevated Myocardial Infarction: A Case Report and Literature Review

  11. 2023

    Turning down the spice: tackling the problems of synthetic cannabinoids

  12. 2023

    Use of psychoactive substances by goods carriage drivers associated with Kerala, India

    DesfavorávelEnsaio ClínicoEfeitos Adversos da CannabisDependência — CannabisPsicose+4
  13. 2022

    A Case of Synthetic Cannabinoid (K2)-Induced Posterior Reversible Encephalopathy Syndrome (PRES)

  14. 2022

    Acute effects of 4-EA-NBOMe, 3, 4-DCMP, LY-2183240 and AB-CHFUPYCA on the excitability of rat cortical primary cultured neurons

    InconclusivoEstudo LaboratorialCanabinoides Sintéticos AB-x
  15. 2022

    Cannabis and orofacial pain: a systematic review

  16. 2022

    Effects of synthetic (JWH-018) cannabinoids treatment on spermatogenesis and sperm function

    DesfavorávelEstudo em AnimaisInfertilidade MasculinaCanabinoides Sintéticos JWH-x
  17. 2022

    Effects of synthetic cannabinoids on psychomotor, sensory and cognitive functions relevant for safe driving

  18. 2022

    Factor-guided diagnosis of coagulopathy associated with coumarin-contaminated synthetic cannabinoids

  19. 2022

    NPS detection in prison: A systematic literature review of use, drug form, and analytical approaches

  20. 2022

    Synthetic cannabinoids and ST elevation myocardial infarction

  21. 2022

    Unexpected short- and long-term effects of chronic adolescent HU-210 exposure on emotional behavior

    InconclusivoEstudo em AnimaisAnsiedadeDepressãoCanabinoides Sintéticos HU-x
  22. 2021

    A systematic review of the label accuracy of cannabinoid-based products in regulated markets: is what's on the label what's in the product?

    InconclusivoMetanáliseEfeitos Adversos da CannabisCanabinoides Sintéticos AB-x
  23. 2021

    Abuse Potential of Synthetic Cannabinoids: AM-1248, CB-13, and PB-22

    DesfavorávelEstudo em AnimaisCanabinoide Sintético (não especificado)Canabinoides Sintéticos AM-x
  24. 2021

    Catatonia Related to Cannabis and Synthetic Cannabinoids: A Review

  25. 2021

    Lethal case of myocardial ischemia following overdose of the synthetic cannabinoid ADB-FUBINACA

  26. 2021

    Natural and Synthetic Cannabinoids: Pharmacology, Uses, Adverse Drug Events, and Drug Interactions

  27. 2021

    Near-Fatal Spice Intoxication of a Toddler

  28. 2021

    New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature

  29. 2021

    Novel Δ8‐Tetrahydrocannabinol Vaporizers Contain Unlabeled Adulterants, Unintended Byproducts of Chemical Synthesis, and Heavy Metals

    DesfavorávelEstudo LaboratorialCanabinoide Sintético (não especificado)Delta-8-THC
  30. 2021

    Overview of Synthetic Cannabinoids ADB-FUBINACA and AMB-FUBINACA: Clinical, Analytical, and Forensic Implications

    DesfavorávelMetanáliseCanabinoide Sintético (não especificado)
  31. 2021

    Pharmacokinetics and Pharmacodynamics of the Synthetic Cannabinoid, 5F-MDMB-PICA, in Male Rats

    DesfavorávelEstudo em AnimaisCanabinoides Sintéticos 5F-x
  32. 2021

    Safety and tolerability of natural and synthetic cannabinoids in adults aged over 50 years: A systematic review and meta-analysis

  33. 2021

    Safety and Tolerability of Natural and Synthetic Cannabinoids in Older Adults: A Systematic Review and Meta-Analysis of Open-Label Trials and Observational Studies

    FavorávelEnsaio ClínicoEfeitos Adversos da CannabisCondições Geriátricas
  34. 2021

    Suicide by vaping the synthetic cannabinoid 4F-MDMB-BINACA: cannabinoid receptors and fluoride at the crossroads of toxicity?

  35. 2021

    Synthetic Cannabinoid-Related Deaths in England, 2012-2019

  36. 2021

    Synthetic Cannabinoids and Cathinones Cardiotoxicity: Facts and Perspectives

  37. 2021

    Synthetic cannabis: adverse events reported to the New Zealand Pharmacovigilance Centre

    DesfavorávelMetanáliseCanabinoide Sintético (não especificado)
  38. 2020

    AB-CHMINACA-induced sudden death from non-cardiogenic pulmonary edema

    InconclusivoMetanáliseCanabinoide Sintético (não especificado)
  39. 2020

    Brodifacoum-Laced Synthetic Marijuana Toxicity: A Fight Against Time

  40. 2020

    Characteristics and circumstances of synthetic cannabinoid-related death

    InconclusivoMetanáliseCanabinoide Sintético (não especificado)
  41. 2020

    Comparison of the Neurotoxic and Seizure-Inducing Effects of Synthetic and Endogenous Cannabinoids with Δ 9-Tetrahydrocannabinol

    DesfavorávelEstudo em AnimaisCanabinoides Sintéticos AM-xCanabinoides Sintéticos JWH-x
  42. 2020

    Emergence of Cumyl-PEGACLONE-related fatalities in the Northern Territory of Australia

  43. 2020

    Neurochemical and Behavioral Characterization after Acute and Repeated Exposure to Novel Synthetic Cannabinoid Agonist 5-MDMB-PICA

    DesfavorávelEstudo em AnimaisCanabinoides Sintéticos 5F-x
  44. 2020

    Synthetic cannabinoid receptor agonists-induced recurrent seizure in elderly patient

    DesfavorávelMetanáliseCanabinoide Sintético (não especificado)
  45. 2020

    Synthetic Cannabinoids and Its Association With Persistent Negative Symptoms of Schizophrenia

  46. 2020

    The other side of the leaf: Seizures associated with synthetic cannabinoid use

    DesfavorávelMetanáliseCanabinoide Sintético (não especificado)
  47. 2020

    The synthetic cannabinoid 5F-MDMB-PICA: A case series

    DesfavorávelMetanáliseCanabinoides Sintéticos 5F-x
  48. 2019

    A case of intoxication with a mixture of synthetic cannabinoids EAM-2201, AB-PINACA and AB-FUBINACA, and a synthetic cathinone α-PVP

    FavorávelMetanáliseCanabinoides Sintéticos AB-x
  49. 2019

    A case report positive for synthetic cannabinoids: are cardiovascular effects related to their protracted use?

    DesfavorávelMetanáliseCanabinoide Sintético (não especificado)
  50. 2019

    Bilateral multiple exudative retinal detachments and macular edema in a patient diagnosed with synthetic cannabinoid (Bonzai) intoxication

    DesfavorávelMetanáliseDoenças da RetinaCanabinoide Sintético (não especificado)
  51. 2019

    Chronic Marijuana and Synthetic Cannabinoid-Induced Toxic Myocarditis and End-Stage Cardiomyopathy: Management With Mechanical Circulatory Support as a Bridge-to-Transplantation

  52. 2019

    Clinical Challenges in Patients with First Episode Psychosis and Cannabis Use: Mini-Review and a Case Study

  53. 2019

    Fatal intoxication of a regular drug user following N-ethyl-hexedrone and ADB-FUBINACA consumption

  54. 2019

    Neurocognition and Subjective Experience Following Acute Doses of the Synthetic Cannabinoid JWH-018: Responders Versus Nonresponders

    DesfavorávelEnsaio ClínicoCanabinoides Sintéticos JWH-x
  55. 2019

    Substance Abuse Poisoning Reported to the Poisons Information Centre Erfurt from 2002 to 2016

    DesfavorávelMetanáliseCanabinoide Sintético (não especificado)
  56. 2019

    Suspected synthetic cannabinoid receptor agonist intoxication: Does analysis of samples reflect the presence of suspected agents?

  57. 2019

    The Relevance of Sex in the Association of Synthetic Cannabinoid Use With Psychosis and Agitation in an Inpatient Population

    DesfavorávelMetanálisePsicoseCanabinoide Sintético (não especificado)
  58. 2018

    A new cause of ischaemic priapism: Synthetic cannabinoids.

    DesfavorávelMetanáliseCanabinoide Sintético (não especificado)
  59. 2018

    Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial

  60. 2018

    Acute myocardial infarction triggered by use of synthetic cannabis.

    DesfavorávelMetanáliseCanabinoide Sintético (não especificado)
  61. 2018

    Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA

  62. 2018

    Evaluation of cognitive functions in individuals with synthetic cannabinoid use disorder and comparison to individuals with cannabis use disorder

    InconclusivoMetanáliseEfeitos Adversos da CannabisDisfunção Cognitiva
  63. 2018

    Excretion of metabolites of the synthetic cannabinoid JWH-018 in urine after controlled inhalation

    InconclusivoEnsaio ClínicoEfeitos Adversos da CannabisCanabinoides Sintéticos JWH-x
  64. 2018

    Ischaemic cardiomyopathy and embolic stroke in a young adult with suspected synthetic cannabinoid use.

  65. 2018

    Neurocognition and subjective experience following acute doses of the synthetic cannabinoid JWH-018: a phase 1, placebo-controlled, pilot study

  66. 2018

    Psychosis and synthetic cannabinoids

    DesfavorávelMetanáliseCanabinoide Sintético (não especificado)
  67. 2018

    Repeated Exposure to the “Spice” Cannabinoid JWH-018 Induces Tolerance and Enhances Responsiveness to 5-HT1A Receptor Stimulation in Male Rats

    DesfavorávelEstudo em AnimaisPsicoseCanabinoides Sintéticos JWH-x
  68. 2018

    Spicing it up - synthetic cannabinoid receptor agonists and psychosis - a systematic review

    DesfavorávelMetanáliseCanabinoide Sintético (não especificado)
  69. 2018

    Synthetic Cannabinoid Induced acute Tubulointerstitial Nephritis and Uveitis Syndrome: A Case Report and Review of Literature

    DesfavorávelMetanáliseCanabinoide Sintético (não especificado)
  70. 2017

    Acute effects of synthetic cannabinoids: Update 2015

    DesfavorávelMetanáliseCanabinoide Sintético (não especificado)
  71. 2017

    Acute Poisonings from Synthetic Cannabinoids — 50 U.S. Toxicology Investigators Consortium Registry Sites, 2010–2015

    DesfavorávelMetanáliseCanabinoide Sintético (não especificado)
  72. 2017

    Antidote to cannabinoid intoxication: the CB1 receptor inverse agonist, AM251, reverses hypothermic effects of the CB1 receptor agonist, CB‐13, in mice

    FavorávelEstudo em AnimaisEfeitos Adversos da CannabisCanabinoides Sintéticos AM-x
  73. 2017

    Cannabis, cannabinoids, and health

    DesfavorávelMetanáliseCanabinoide Sintético (não especificado)
  74. 2017

    Dermatological aspects of synthetic cannabinoid addiction

  75. 2017

    Focus on cannabinoids and synthetic cannabinoids

    DesfavorávelMetanáliseCanabinoide Sintético (não especificado)
  76. 2017

    Hepatotoxicity Associated to Synthetic Cannabinoids Use

    DesfavorávelMetanáliseHepatotoxicidadeCanabinoide Sintético (não especificado)
  77. 2017

    Ischemic stroke associated with the use of a synthetic cannabinoid (spice).

    DesfavorávelMetanáliseCanabinoide Sintético (não especificado)
  78. 2017

    Natural (∆9-THC) and synthetic (JWH-018) cannabinoids induce seizures by acting through the cannabinoid CB1 receptor

    InconclusivoEstudo em AnimaisEpilepsiaCanabinoides Sintéticos AM-xCanabinoides Sintéticos JWH-x
  79. 2017

    Spice-y Kidney Failure: A Case Report and Systematic Review of Acute Kidney Injury Attributable to the Use of Synthetic Cannabis

    DesfavorávelMetanáliseCanabinoide Sintético (não especificado)
  80. 2017

    Strokes are possible complications of cannabinoids use

    InconclusivoMetanáliseAVC
  81. 2017

    Supraventricular tachycardia and acute confusion following ingestion of e-cigarette fluid containing AB-FUBINACA and ADB-FUBINACA: a case report with quantitative analysis of serum drug concentrations

  82. 2017

    Synthetic Cannabinoids: Psychopharmacology, Clinical Aspects, Psychotic Onset

    DesfavorávelMetanáliseCanabinoide Sintético (não especificado)
  83. 2017

    Synthetic Cannabis Analogues and Suicidal Behavior: Case Report

  84. 2017

    The effects of synthetic cannabinoid UR-144 on the human body-A review of 39 cases

    DesfavorávelMetanáliseCanabinoide Sintético (não especificado)
  85. 2016

    A preliminary evaluation of synthetic cannabinoid use among adolescent cannabis users: Characteristics and treatment outcomes

  86. 2016

    Acute Toxicity Associated with Use of 5F-Derivations of Synthetic Cannabinoid Receptor Agonists with Analytical Confirmation

    DesfavorávelMetanálise
  87. 2016

    Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues

    FavorávelMetanáliseCanabinoides Sintéticos 5F-x
  88. 2016

    Psychiatric comorbidity associated with synthetic cannabinoid use compared to cannabis

    DesfavorávelMetanáliseCanabinoide Sintético (não especificado)
  89. 2016

    Repeated Thrombosis After Synthetic Cannabinoid Use.

  90. 2016

    Sickle Cell Crisis Complicated by Synthetic Cannabinoid Abuse: A Case Report

    DesfavorávelMetanáliseDoença FalciformeCanabinoide Sintético (não especificado)
  91. 2016

    Signs and symptoms associated with synthetic cannabinoid toxicity: systematic review

    DesfavorávelMetanáliseCanabinoide Sintético (não especificado)
  92. 2016

    Suicide attempt with a mix of synthetic cannabinoids and synthetic cathinones: Case report of non-fatal intoxication with AB-CHMINACA, AB-FUBINACA, alpha-PHP, alpha-PVP and 4-CMC

    DesfavorávelMetanáliseTentativa de SuicídioCanabinoides Sintéticos AB-x
  93. 2016

    Synthetic cannabinoid hyperemesis resulting in rhabdomyolysis and acute renal failure

  94. 2015

    A Common Source Outbreak of Severe Delirium Associated with Exposure to the Novel Synthetic Cannabinoid ADB-PINACA

    FavorávelMetanálisePsicoseCanabinoides Sintéticos AB-x
  95. 2015

    A New Differential Diagnosis: Synthetic Cannabinoids-Associated Acute Renal Failure

    DesfavorávelMetanáliseCanabinoide Sintético (não especificado)
  96. 2015

    Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135

    DesfavorávelEstudo em AnimaisCanabinoide Sintético (não especificado)Canabinoides Sintéticos AM-x+2
  97. 2015

    Intraperirhinal cortex administration of the synthetic cannabinoid, HU210, disrupts object recognition memory in rats

  98. 2015

    K2--not the spice of life; synthetic cannabinoids and ST elevation myocardial infarction: a case report.

  99. 2015

    Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA

    FavorávelEstudo LaboratorialCanabinoides Sintéticos 5F-xCanabinoides Sintéticos AB-x
  100. 2015

    The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects

    DesfavorávelMetanáliseCanabinoide Sintético (não especificado)
  101. 2014

    "Spice"--synthetic cannabinoids with dangerous effects

    DesfavorávelMetanáliseCanabinoide Sintético (não especificado)
  102. 2014

    A case of acute cerebral ischemia following inhalation of a synthetic cannabinoid

    DesfavorávelMetanáliseAVCCanabinoide Sintético (não especificado)
  103. 2014

    Four postmortem case reports with quantitative detection of the synthetic cannabinoid, 5F-PB-22

  104. 2014

    Ischemic stroke after use of the synthetic marijuana "spice"

  105. 2014

    Pharmacology, Toxicology, and Adverse Effects of Synthetic Cannabinoid Drugs

  106. 2014

    Smoking synthetic marijuana leads to self-mutilation requiring bilateral amputations

    DesfavorávelMetanáliseCanabinoide Sintético (não especificado)
  107. 2014

    Synthetic cannabinoid leading to cannabinoid hyperemesis syndrome

  108. 2014

    Synthetic Cannabis Substances (SPS) Use and Hallucinogen Persisting Perception Disorder (HPPD): Two Case Reports

    FavorávelMetanáliseAnsiedadeCanabinoide Sintético (não especificado)
  109. 2013

    "Spiceophrenia": a systematic overview of "spice"-related psychopathological issues and a case report

    DesfavorávelMetanálisePsicoseEsquizofreniaCanabinoides Sintéticos JWH-x
  110. 2013

    Acute Psychosis Associated with Recreational Use of Benzofuran 6-(2-Aminopropyl)Benzofuran (6-APB) and Cannabis

    DesfavorávelMetanáliseCanabinoide Sintético (não especificado)
  111. 2013

    Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings

  112. 2013

    AKI Associated with Synthetic Cannabinoids: A Case Series

    DesfavorávelMetanáliseCanabinoide Sintético (não especificado)
  113. 2013

    An accidental fatal intoxication with methoxetamine

  114. 2013

    Driving under the influence of synthetic cannabinoids ("Spice"): a case series

  115. 2013

    Effects of the Cannabinoid-1 Receptor Antagonist/Inverse Agonist Rimonabant on Satiety Signaling in Overweight People with Schizophrenia

  116. 2013

    K2 Toxicity: Fatal Case of Psychiatric Complications Following AM2201 Exposure†

  117. 2013

    Synthetic cannabinoid overdose in a 20-year-old male US soldier

    DesfavorávelMetanáliseCanabinoide Sintético (não especificado)
  118. 2012

    Acute mental disturbance caused by synthetic cannabinoid: a potential emerging substance of abuse in Hong Kong

    DesfavorávelMetanáliseCanabinoide Sintético (não especificado)
  119. 2012

    An accidental fatal intoxication with methoxetamine

    DesfavorávelMetanáliseCanabinoides Sintéticos AM-xCanabinoides Sintéticos JWH-x
  120. 2012

    Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?

  121. 2012

    Does rimonabant independently affect free fatty acid and glucose metabolism?

  122. 2012

    Efficacy of rimonabant in obese patients with binge eating disorder

  123. 2012

    Fatty acid flux and oxidation are increased by rimonabant in obese women

  124. 2012

    Rimonabant improves obesity but not the overall cardiovascular risk and quality of life; results from CARDIO-REDUSE (CArdiometabolic Risk reDuctIOn by Rimonabant: the Effectiveness in Daily practice and its USE)

  125. 2012

    Spice, bath salts, and the U.S. military: the emergence of synthetic cannabinoid receptor agonists and cathinones in the U.S. Armed Forces

    DesfavorávelMetanáliseCanabinoide Sintético (não especificado)
  126. 2011

    A randomized, double-blind, placebo-controlled, crossover study to evaluate the subjective abuse potential and cognitive effects of nabiximols oromucosal spray in subjects with a history of recreational cannabis use

  127. 2011

    ANKK1/DRD2 locus variants are associated with rimonabant efficacy in aiding smoking cessation: pilot data

  128. 2011

    CB1 - cannabinoid receptor antagonist effects on cortisol in cannabis-dependent men

  129. 2011

    Rimonabant for neurocognition in schizophrenia: a 16-week double blind randomized placebo controlled trial

  130. 2011

    Synthetic cannabinoid JWH-018 and psychosis: an explorative study

    DesfavorávelMetanálisePsicoseCanabinoides Sintéticos JWH-x
  131. 2011

    Synthetic delta-9-tetrahydrocannabinol elicits schizophrenia-like negative symptoms which are distinct from sedation

    FavorávelEnsaio Clínico Duplo-CegoTHC Farmacêutico
  132. 2010

    Neuropsychiatric adverse effects signal the end of the line for rimonabant

  133. 2010

    The synthetic cannabinoid Spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes

    DesfavorávelMetanáliseCanabinoide Sintético (não especificado)
  134. 2009

    Withdrawal Phenomena and Dependence Syndrome After the Consumption of "Spice Gold"

    DesfavorávelMetanáliseCanabinoides Sintéticos JWH-xCanabinoides Sintéticos CP-x
  135. 2000

    Inhibitory effects of the cannabinoid agonist HU 210 on rat sexual behaviour

    DesfavorávelEstudo em AnimaisLibidoDisfunção ErétilCanabinoides Sintéticos HU-x
  136. 1999

    Learning impairment produced in rats by the cannabinoid agonist HU 210 in a water-maze task

    DesfavorávelEstudo em AnimaisEfeitos Adversos da CannabisCanabinoides Sintéticos HU-x
  137. 1977

    A cannabinoid with cardiovascular activity but no overt behavioral effects

Continue por aqui

Perguntas frequentes

Quantos estudos sobre intoxicação por cannabis sintética estão indexados no acervo?
São 137 estudos, publicados entre 1977 e 2023. O acervo inteiro tem 7.640 registros.
Que tipos de estudo predominam?
Metanálise: 95 · Estudo em Animais: 15 · Ensaio Clínico: 12 · Ensaio Clínico Duplo-Cego: 9 · Estudo Laboratorial: 5 · Metanálise Clínica: 1. A classificação segue o desenho declarado na fonte.
O que significa a classificação de resultado?
É uma leitura automatizada da conclusão de cada estudo, em três direções — favorável, inconclusivo e desfavorável. Aqui são 24 favoráveis, 14 inconclusivos e 99 desfavoráveis. Serve para navegar o acervo, não para concluir nada clinicamente: a conclusão válida é a do artigo original.

Como citar esta página

ABNT

CANNABIS INDICA. Intoxicação por Cannabis Sintética — estudos científicos sobre cannabis. 2026. Disponível em: https://cannabisindica.com.br/condicao/intoxicacao-por-cannabis-sintetica/. Acesso em: 13 set. 2026.

APA

Cannabis Indica. (2026). Intoxicação por Cannabis Sintética — estudos científicos sobre cannabis. https://cannabisindica.com.br/condicao/intoxicacao-por-cannabis-sintetica/

Esta página é um índice de acesso. Ao usar um estudo como evidência, cite o artigo original — o link de cada registro leva à fonte.